In vitro synergistic combinations of pentamidine, polymyxin B, tigecycline and tobramycin with antifungal agents against Fusarium spp.-Reference-Cited by-同舟云学术

In vitro synergistic combinations of pentamidine, polymyxin B, tigecycline and tobramycin with antifungal agents against Fusarium spp.

Published:2016-08-01 Issue:8 Volume:65 Page:770-774
ISSN:0022-2615
Container-title:Journal of Medical Microbiology
language:en
Short-container-title:

Author:

Pozzebon Venturini Tarcieli¹,Rossato Luana¹,Chassot Francieli¹,Tairine Keller Jéssica²,Baldissera Piasentin Fernanda¹,Morais Santurio Janio²³,Hartz Alves Sydney¹²

Affiliation:

1. Postgraduate Program in Pharmaceutical Sciences, Health Sciences Center, Federal University of Santa Maria (UFSM), Santa Maria, RS, Brazil

2. Department of Microbiology and Parasitology, Federal University of Santa Maria (UFSM), Santa Maria, RS, Brazil

3. Postgraduate Program in Pharmacology, Health Sciences Center, Federal University of Santa Maria (UFSM), Santa Maria, RS, Brazil

Publisher

Microbiology Society

Subject

Microbiology (medical),General Medicine,Microbiology

Reference32 articles.

1. In Vitro Synergistic Interaction between Amphotericin B and Pentamidine against Scedosporium prolificans

2. Fusarium: Molecular Diversity and Intrinsic Drug Resistance

3. Pharmacokinetics of Tobramycin in Adults with Cystic Fibrosis: Implications for Once-Daily Administration

4. Use of a New Bioassay to Study Pentamidine Pharmacokinetics

5. Tobramycin-responsive Fusarium oxysporum keratitis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies of Pharmacological Repositioning for the Treatment of Medically Relevant Mycoses;Infection and Drug Resistance;2024-06

2. Caspofungin alone or combined with polymyxin B are effective against mixed biofilm of Aspergillus fumigatus and carbapenem-resistant Pseudomonas aeruginosa;Research in Microbiology;2023-01

3. Repurposing non-antifungal drugs auranofin and pentamidine in combination as fungistatic antifungal agents against C. albicans;Frontiers in Cellular and Infection Microbiology;2022-12-15

4. Novel avenues for identification of new antifungal drugs and current challenges;Expert Opinion on Drug Discovery;2022-07-21

5. Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox;Pharmaceuticals;2022-04-14